✅Improved overall survival ✅Improved compliance to clinical practice guidelines ✅📈 pre-surgery biopsies ✅📈 pre-surgery presentation at the NETSARC MDTB ✅📈 R0 resection on first surgery ✅📉R2 resection 2/2

Wow! Yes!

"Desmoid tumors can result in significant impact on functioning and quality of life of patients." - Dr. Shivaani Kummar, who conducted the Phase 2 clinical trial study for the drug nirogacestat (a treatment of desmoid tumors): spr.ly/6016Vy7wm

More from Dr. Shivaani Kummar on treatment options for desmoid tumors ⤵️ #RareDiseaseDay2024

Dr. LisaCoussens@CoussensLab's work “led a shift in the way we think of cancer, from a bunch of cells in isolation to considering how the surrounding microenvironment around the tumors can be exploited to develop better anti-cancer therapies.” #WomensHistoryMonth: spr.ly/6016kJt1I

The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promising efficacy in synovial sarcoma and MRCLS paving the way for T cell therapy in solid tumors. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Sarcoma Service at Memorial Sloan Kettering sciencedirect.com/science/articl…

This. Thanks.

I made a video. Please keep sharing. I need this to go viral for our case to the U.S. FDA

💪 Crush Cancer 🗓️ May 18 ⏰ 8 am 📍 Faith Hope & Charity Vineyards Enjoy the gorgeous scenery during the "Crush Cancer" race and walk benefiting OHSU Knight Cancer Institute to support Central Oregon Families battling cancer and facing financial need: spr.ly/6010bTqPA

propublica.org/article/cigna-… ProPublica has done it again. These terrifying glimpses inside health insurance corporations are so important. People need to understand what we're up against. These corporations don't care about you. Cigna Healthcare

It was a blast writing a chapter on updated approaches to #MPNST #sarcoma with Carina Dehner, MD PhD, Dombi, Eulo, Gross, Lazar and lead Angela Hirbe for the ASCO education book. Check it out doi.org/10.1200/EDBK_4… and don’t miss the paired #ASCO2024 panel 5/31 4:30p S102! #ENDNF

Two #SARCtrials have been selected for oral presentation at #ASCO24. SARC032 and SARC037 will be presented Monday, June 3rd during the #sarcoma session from 3-6pm CDT. See more here: sarctrials.org/sarc-sponsored… #ASCO2024 #ASCO #clinicaltrial

Powerhouse panel! SARC hosting a review of SARC028 data on #ICI in #sarcoma - followed by a cage fight / debate on TLS as a biomarker! Moderated by the unmatched Sandra P D'Angelo, MD

Not sure about this new FORP acronym 🧐 Reminds me of trail mix (showing my age!) rather than Females Of Reproductive Potential. Nonetheless! Glad to see these data prospectively collected on #desmoid trials, as Dr Loggers discussed #ASCO2024

It is grossly irresponsible to say that these 5 unsupported claims mean the pandemic “probably” started with a lab leak. They misrepresent the actual evidence and put people like Dr. Fauci at great risk. The New York Times Opinion has shamed itself by printing untruths & outright lies.

As the sun sets on #asco24 I’d be remiss not to say that I’m worried about my colleagues I worry we are crushing one another with colossal expectations, with our emails & CVs You are more than your publications & presentations Please don’t tie your self-worth to brass rings

New outlook signature just dropped

Hells yeah Massachusetts.

What it’s like to be in healthcare right now: “We will pay you $2 for that pie” “But it costs me $4 in pie ingredients and $2 in human labor to make a pie. We need $6 to break even” “Sorry, we’ll only pay you $2 for that pie. We suggest you make many more pies that you also

Dear Doctors, Happy annual cut-your-compensation day. This one comes with an additional demand for you to change your practice to address “whole body care” and spend lots of administrative overhead proving your “quality” with metrics that are mostly gamesmanship and complex